Invention Grant
- Patent Title: Compounds for the treatment of conditions associated with DGAT1 activity
-
Application No.: US14630624Application Date: 2015-02-24
-
Publication No.: US09242971B2Publication Date: 2016-01-26
- Inventor: Christina Capacci-Daniel , Marilyn Delacruz , Baoqing Gong , Akash Jain , Yansong Lu , Lijun Zhang
- Applicant: Christina Capacci-Daniel , Marilyn Delacruz , Baoqing Gong , Akash Jain , Yansong Lu , Lijun Zhang
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent Joshua Roth
- Main IPC: C07D413/00
- IPC: C07D413/00 ; C07D413/12 ; A61K31/4439 ; A61K45/06
Abstract:
The present invention relates to novel crystalline forms of salts of 2-((1R,4R)-4-(4-(5-(benzo[d]oxazol-2-ylamino)pyridin-2-yl)phenyl)cyclohexyl)acetic acid and their use in the treatment or prevention of a condition or a disorder associated with DGAT1 activity in animals, particularly humans.
Public/Granted literature
- US20150166522A1 COMPOUNDS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH DGAT1 ACTIVITY Public/Granted day:2015-06-18
Information query
